Inflammatory Marker Articles & Analysis
2 articles found
Secukinumab, an IL-17A sequestering agent used in treating psoriasis, was selected as a repurposed candidate to address the sequential inflammatory disorders that follow the first metabolic insult. Conclusions Our analysis suggests this novel combinatorial therapeutic approach inducing DPP4 and Il-17a suppression has a high likelihood of ameliorating a significant portion of the ...
In addition, the proportion of CRP (C-reactive protein) and SAA (serum amyloid A) increased before death was 85% and 100%, respectively. CRP is an inflammatory marker, which plays an important role in host defense against invading pathogens and inflammation. ...